IP Library › Granted Patent US 8,088,779
Granted Patent B2
US 8,088,779 · App. 12/067,939 · Granted Jan 3, 2012

Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,088,779
App. No.
12/067,939
Granted
Jan 3, 2012
Kind
B2
Abstract

The present invention generally relates to the polymorph Form 2 of [3-(4-methoxy-2-methyl-phenyl)-2,5-dimethyl-pyrazolo[1,5-a]pyrimidin-7-yl]-[(S)-1-(3-methyl-[1,2,4]oxa-diazol-5-yl)-propyl]amine. The present invention also relates to pharmaceutical compositions comprising the same and methods of using the same.

Claims (2)

1. Crystalline Form 2 of [3-(4-methoxy-2-methyl-phenyl)-2,5-dimethyl-pyrazolo[1,5-a]pyrimidin-7-yl]-[(S)-1-(3-methyl-[1,2,4]oxadiazol-5-yl)-propyl]-amine.

2. A composition comprising crystalline Form 2 of [3-(4-methoxy-2-methyl-phenyl)-2,5-dimethyl-pyrazolo[1,5-a]pyrimidin-7-yl]-[(S)-1-(3-methyl-[1,2,4]oxadiazol-5-yl)-propyl]-amine according to claim 1 and a pharmaceutically acceptable carrier.

Assignments (4)
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded May 26, 2026
From: NEUROCRINE BIOSCIENCES, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075670/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2013
From: SMITHKLINE BEECHAM (CORK) LTD.
To: NEUROCRINE BIOSCIENCES, INC.
Reel/Frame 029640/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2008
From: SB PHARMCO PUERTO RICO INC.
To: SMITHKLINE BEECHAM (CORK) LIMITED
Reel/Frame 021411/0785 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2008
From: HOSSNER, FRANK
To: SB PHARMCO PUERTO RICO INC.; NEUROCRINE BIOSCIENCES INC.
Reel/Frame 021210/0039 →